LINC00632
Description
The LINC00632 (long intergenic non-protein coding RNA 632) is a ncRNA gene located on chromosome X.
LINC00632 is a long non-coding RNA (lncRNA) that is located on chromosome 10. It is approximately 1,300 nucleotides in length and is transcribed from the opposite strand of the gene ATP1A1, which encodes the alpha-1 subunit of the Na+/K+ ATPase. LINC00632 has been shown to be involved in a variety of cellular processes, including cell proliferation, apoptosis, and immune response. Its expression has been found to be dysregulated in several types of cancer, suggesting its potential role in cancer development and progression. Further research is needed to fully understand the function and regulation of LINC00632.
LINC00632 is a long non-coding RNA (lncRNA) that has been implicated in various cellular processes, including cell proliferation, apoptosis, and immune response. Studies have shown that LINC00632 expression is dysregulated in various cancers, suggesting its potential role in cancer development and progression. For instance, LINC00632 has been found to be upregulated in colorectal cancer, hepatocellular carcinoma, and breast cancer, where it promotes tumor growth and metastasis. Conversely, LINC00632 has also been reported to be downregulated in other cancers, such as lung cancer and gastric cancer, where it may act as a tumor suppressor. Further research is needed to fully elucidate the precise mechanisms by which LINC00632 contributes to cancer pathogenesis.
LINC00632 is also known as ARST, ASINC, BMOR, CDR1-AS, CDR1NAT, CDR1as, MDHDH, ciRS-7.
Associated Diseases
- cancer
- breast cancer
- urinary bladder carcinoma
- nail-patella syndrome
- microphthalmia with limb anomalies
- achalasia-alacrima syndrome
